Ovarian Cancer
Theolytics Limited is engaged in clinical research for high grade serous ovarian cancer and endometrioid ovarian cancer, with a focus on advanced gynaecological oncology.
- Ovarian cancer
- High grade serous carcinoma
- Endometrioid carcinoma
The sponsor’s research activity is centred on treatment development for patients with difficult-to-treat ovarian malignancies.
Oncology Therapeutics
Its clinical programme reflects interest in anticancer therapy evaluation, with emphasis on safety, tolerability, and early signs of antitumour activity in solid tumours.
- Anticancer treatment
- Solid tumour therapy
- Therapeutic efficacy
The research portfolio is aligned with the development of new oncology medicines for gynaecological cancers.
Clinical Development in Early-Stage Cancer Research
The sponsor is involved in early clinical investigation supporting the assessment of novel cancer therapeutics in patients with ovarian cancer.
- Early clinical evaluation
- Safety and tolerability
- Antitumour response
This work contributes to the clinical exploration of new treatment options in oncology.
Imaging-Based Cancer Assessment
Research activity also includes the use of computed tomography and magnetic resonance imaging to assess treatment response in ovarian cancer.
- CT imaging
- MRI
- RECIST criteria
These areas support the evaluation of disease burden and objective response in gynaecological oncology.
